Image of front of Bedfont Scientific Ltd

News

Take a look at the news articles below to see what we have been getting up to at Bedfont® and all of our latest news.

Setting the standard for wellbeing: Kent Business Awards celebrate Bedfont® Scientific Limited’s impact

Setting the standard for wellbeing: Kent Business Awards celebrate Bedfont® Scientific Limited’s impact

Bedfont® is recognised for putting people first and scoops the AHM Health & Wellbeing Award. Bedfont® Scientific Limited, an innovative MedTech company that has just celebrated its 49th anniversary, is thrilled to have won the All Health Matters (AHM) Health...
Read More
Life-saving Christmas present arrives early at Medway United FC

Life-saving Christmas present arrives early at Medway United FC

Bedfont® Scientific Limited strengthens community safety with defibrillator donation. Bedfont® Scientific Limited, an innovative MedTech company with over 48 years of experience in breath analysis, has proudly donated a defibrillator to Medway United FC. The club is an integral part...
Read More
Holiday eating and gut health: how hydrogen-methane breath testing (HMBT) can help

Holiday eating and gut health: how hydrogen-methane breath testing (HMBT) can help

With the festive holiday season upon us, many tend to indulge in the various rich, festive treats on offer. December is a joyful time; it is also a time to relax and treat yourself; however, the festive eating can take...
Read More
Bedfont® Scientific Limited Expands Global Access to FeNO Testing in India

Bedfont® Scientific Limited Expands Global Access to FeNO Testing in India

Rbeck Healthtech Private completes registration for the NObreath® FeNO device, helping to improve asthma care across the region. Bedfont® Scientific Limited, world leaders in breath analysis, with over 48 years of experience in designing and manufacturing medical breath analysis devices,...
Read More
Practical insights for asthma care: The new NICE/BTS/SIGN guidelines. Why FeNO first?

Practical insights for asthma care: The new NICE/BTS/SIGN guidelines. Why FeNO first?

Part 3: Asthma treatment in 2024: Navigating the new recommendations for every age After exploring diagnostic changes and the pivotal role of Fractional exhaled Nitric Oxide (FeNO) in asthma care, part 3 of our series shifts the focus to treatment...
Read More
Practical insights for asthma care: The new NICE/BTS/SIGN guidelines. Why FeNO first?

Practical insights for asthma care: The new NICE/BTS/SIGN guidelines. Why FeNO first?

Part 2: Why FeNO first? Spotlight on testing & special cases In Part 1, we explored the redefined approach to asthma diagnosis under the new NICE/BTS/SIGN guidelines. In Part 2, we dive deeper into the role of Fractional exhaled Nitric...
Read More
1 2 3 34
Back to top